🔗 Share this article

A shadow market for unapproved weight-loss medications is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.

Investigational Drug Acquiring Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged weight-reducing effects. Viewers are urged to message these profiles directly for source information, while also receiving discount codes.

Active Commerce on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where groups with thousands of participants share comparison images, administration instructions and assertions of next-day UK delivery. Vendors promote the drug there before directing customers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Professionals Voice Concerns

However, physicians and chemists have cautions that the sale of what is still an unapproved medication in the UK is a cause for concern and could result in users injecting substances of unknown origin.

Several professionals said the demand for retatrutide could be linked to the rising cost of licensed slimming treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for human use under the British medical regulations.

Several content creators attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach medicines, marketing, and consumer laws, risking penalties, legal action or imprisonment.

Service Response and Material Removal

According to TikTok, the platform has taken down violative content and prohibited related keywords and query recommendations. The organization said it was dedicated to keeping the platform safe and allocating resources in strengthening enforcement strategies.

Digital Trading Operations

Research also found communities with up to nine thousand members marketing retatrutide using the platform's integrated discovery tool, which functions like a public directory. Typing “retatrutide” instantly brings up groups with numerous of users, filled with images of weight loss, glowing testimonials and detailed guides for preparing or injecting at home.

Within minutes of joining one community, a vendor shared contact information, where the majority of purchases occur. The vendor provided an instruction manual and guaranteed delivery within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about weight, medical conditions or previous experience.

Product Details and Costs

Inside these communities, posts display black plastic packages with Royal Mail stickers, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at residence with sterile water, or ready-to-use injectors typically sold at 160 pounds for 20mg. When asked how long a pen should be used, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A representative for Telegram stated it regularly monitored harmful content on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering materials they cannot confirm. Although the research behind this drug is sound, these online versions may not include what they claim,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the surge in demand to current cost increases for authorized slimming medications such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the conditions they were produced in was clean,” she said.

Her staff has previously seen individuals harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or communication platforms is taking chances with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company experimental product not yet authorized … may expose patients to possibly serious health risks”.